Meta-analysis of associations between interleukin-10 polymorphisms and susceptibility to Behcet’s disease

  • Young Ho LeeEmail author
  • Gwan Gyu Song
Original Article


The aim of this study was to determine whether interleukin-10 (IL-10) polymorphisms are associated with susceptibility to Behcet’s disease (BD). A meta-analysis was conducted, examining the associations between the IL-10 − 1082 G/A, − 819 C/T, and − 592 C/A polymorphisms and BD in various ethnic groups. Fourteen studies involving 5992 patients and 8966 controls were considered in the meta-analysis. Meta-analysis of the IL-10 − 1082 G/A polymorphism showed no association between BD and the − 1082 G allele (odds ratio (OR) = 0.951, 95% confidence interval (CI) = 0.790–1.146, p = 0.601). Meta-analysis of the IL-10 − 819 C/T polymorphism revealed a significant association between BD and the − 819 C allele (OR = 0.751, 95% CI = 0.684–0.825, p < 0.001) in all study subjects. Stratification by ethnicity indicated a significant association between the − 819 C allele and BD in Turkish (OR = 0.779, 95% CI = 0.709–0.856, p < 0.001) and Asian (OR = 0.676, 95% CI = 0.631–0.725, p < 0.001), but not in Middle Eastern populations. Meta-analysis of the − 592 C allele showed an association with BD in all study subjects (OR = 0.792, 95% CI = 0.662–0.948, p = 0.011) Stratification by ethnicity indicated a significant association between the − 592 C allele and BD in Asian populations (OR = 0.656, 95% CI = 0.512–0.841, p = 0.001). This meta-analysis showed that the IL-10 − 819 C/T and − 592 C/A polymorphisms are associated with BD susceptibility, especially in Asian population.


Behcet’s disease Interleukin-10 Polymorphism Meta-analysis 


Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.


  1. 1.
    Sakane T, Takeno M, Suzuki N, Inaba G. Behcet’s disease. N Engl J Med. 1999;341:1284–91.CrossRefGoogle Scholar
  2. 2.
    Criteria for diagnosis of Behcet’s disease. International Study Group for Behcet’s Disease. Lancet. 1990;335:1078–80.Google Scholar
  3. 3.
    Moore KW, de Waal MR, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001;19:683–765.CrossRefGoogle Scholar
  4. 4.
    Taga K, Tosato G. IL-10 inhibits human T cell proliferation and IL-2 production. J Immunol. 1992;148:1143–8.PubMedGoogle Scholar
  5. 5.
    Eskdale J, Wordsworth P, Bowman S, Field M, Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens. 1997;49:635–9.CrossRefGoogle Scholar
  6. 6.
    Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24:1–8.CrossRefGoogle Scholar
  7. 7.
    Guzowski D, Chandrasekaran A, Gawel C, Palma J, Koenig J, Wang XP, et al. Analysis of single nucleotide polymorphisms in the promoter region of interleukin-10 by denaturing high-performance liquid chromatography. J Biomol Tech. 2005;16:154–66.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Lopez P, Gutierrez C, Suarez A. IL-10 and TNFalpha genotypes in SLE. J Biomed Biotechnol. 2010;838390.Google Scholar
  9. 9.
    Vázquez-Villamar M, Palafox-Sánchez C, Hernández-Bello J, Muñoz-Valle J, Valle Y, Cruz A, et al. Frequency distribution of interleukin-10 haplotypes (-1082 A> G,-819 C> T, and-592 C> A) in a Mexican population. Genet Mol Res. 2016;15:1–11.CrossRefGoogle Scholar
  10. 10.
    Monach PA, Merkel PA. Genetics of vasculitis. Curr Opin Rheumatol. 2010;22:157–63.CrossRefGoogle Scholar
  11. 11.
    Afkari B, Babaloo Z, Dolati S, Khabazi A, Jadidi-Niaragh F, Talei M, et al. Molecular analysis of interleukin-10 gene polymorphisms in patients with Behcet’s disease. Immunol Lett. 2018;194:56–61.CrossRefGoogle Scholar
  12. 12.
    Baris S, Akyurek O, Dursun A, Akyol M. The impact of the IL-1beta, IL-1Ra, IL-2, IL-6 and IL-10 gene polymorphisms on the development of Behcet’s disease and their association with the phenotype. Med Clin (Barc). 2016;146:379–83.CrossRefGoogle Scholar
  13. 13.
    Yu H, Zheng M, Zhang L, Li H, Zhu Y, Cheng L, et al. Identification of susceptibility SNPs in IL10 and IL23R-IL12RB2 for Behcet’s disease in Han Chinese. J Allergy Clin Immunol. 2017;139:621–7.CrossRefGoogle Scholar
  14. 14.
    Hu J, Hou S, Zhu X, Fang J, Zhou Y, Liu Y, et al. Interleukin-10 gene polymorphisms are associated with Behcet’s disease but not with Vogt-Koyanagi-Harada syndrome in the Chinese Han population. Mol Vis. 2015;21:589–603.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Carapito R, Shahram F, Michel S, le Gentil M, Radosavljevic M, Meguro A, et al. On the genetics of the silk route: association analysis of HLA, IL10, and IL23R-IL12RB2 regions with Behcet’s disease in an Iranian population. Immunogenetics. 2015;67:289–93.CrossRefGoogle Scholar
  16. 16.
    Al-Okaily F, Arfin M, Al-Rashidi S, Al-Balawi M, Al-Asmari A. Inflammation-related cytokine gene polymorphisms in Behçet’s disease. J Inflamm Res. 2015;8:173.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Talaat RM, Ashour ME, Bassyouni IH, Raouf AA. Polymorphisms of interleukin 6 and interleukin 10 in Egyptian people with Behcet’s disease. Immunobiology. 2014;219:573–82.CrossRefGoogle Scholar
  18. 18.
    Wu Z, Zheng W, Xu J, Sun F, Chen H, Li P, et al. IL10 polymorphisms associated with Behcet’s disease in Chinese Han. Hum Immunol. 2014;75:271–6.CrossRefGoogle Scholar
  19. 19.
    Montes-Cano MA, Conde-Jaldon M, Garcia-Lozano JR, et al. HLA and non-HLA genes in Behcet’s disease: a multicentric study in the Spanish population. Arthritis Res Ther. 2013;15:R145.CrossRefGoogle Scholar
  20. 20.
    Shahram F, Nikoopour E, Rezaei N, Saeedfar K, Ziaei N, Davatchi F, et al. Association of interleukin-2, interleukin-4 and transforming growth factor-beta gene polymorphisms with Behcet’s disease. Clin Exp Rheumatol. 2011;29:S28–31.PubMedGoogle Scholar
  21. 21.
    Ates O, Dalyan L, Hatemi G, Hamuryudan V, Topal-Sarikaya A. Analyses of functional IL10 and TNF-alpha genotypes in Behcet’s syndrome. Mol Biol Rep. 2010;37:3637–41.CrossRefGoogle Scholar
  22. 22.
    Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet. 2010;42:703–6.CrossRefGoogle Scholar
  23. 23.
    Dilek K, Ozcimen AA, Saricaoglu H, Saba D, Yucel A, Yurtkuran M, et al. Cytokine gene polymorphisms in Behcet’s disease and their association with clinical and laboratory findings. Clin Exp Rheumatol. 2009;27:S73–8.PubMedGoogle Scholar
  24. 24.
    Wallace GR, Kondeatis E, Vaughan RW, Verity DH, Chen Y, Fortune F, et al. IL-10 genotype analysis in patients with Behcet’s disease. Hum Immunol. 2007;68:122–7.CrossRefGoogle Scholar
  25. 25.
    Lee YH. Association between the neutrophil-to-lymphocyte ratio, and platelet-to-lymphocyte ratio and rheumatoid arthritis and their correlations with the disease activity: a meta-analysis. J Rheum Dis. 2018;25:169–78.CrossRefGoogle Scholar
  26. 26.
    Lee YH. Meta-analysis of genetic association studies. Ann Lab Med. 2015;35:283–7.CrossRefGoogle Scholar
  27. 27.
    Lee YH, Song GG. Causal association between rheumatoid arthritis with the increased risk of type 2 diabetes: a Mendelian randomization analysis. J Rheum Dis. 2019;26:131–6.CrossRefGoogle Scholar
  28. 28.
    Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.CrossRefGoogle Scholar
  29. 29.
    Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.CrossRefGoogle Scholar
  30. 30.
    Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315:1533–7.CrossRefGoogle Scholar
  31. 31.
    DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.CrossRefGoogle Scholar
  32. 32.
    Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.CrossRefGoogle Scholar
  33. 33.
    Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 1999;42:1101–8.CrossRefGoogle Scholar
  34. 34.
    Eskdale J, Kube D, Tesch H, Gallagher G. Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence. Immunogenetics. 1997;46:120–8.CrossRefGoogle Scholar
  35. 35.
    Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci. 1998;95:9465–70.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Rheumatology, Korea University Anam HospitalKorea University College of MedicineSeoulSouth Korea

Personalised recommendations